The data of Figs. 2 and 3 testified that melittin inactivated the YAP/HIF-1α pathway via up-regulation of LATS2 to inhibit hypoxia-induced cell proliferation, glycolysis and angiogenesis in NSCLC cells. Here, LATS2 is linked to non-small cell lung carcinoma.